Unique ID issued by UMIN | UMIN000022547 |
---|---|
Receipt number | R000025988 |
Scientific Title | Safety and efficacy of Kamikihito for the treatment of anxiety and insomnia in castration resistant prostate cancer patients |
Date of disclosure of the study information | 2016/06/02 |
Last modified on | 2021/12/06 13:56:39 |
Safety and efficacy of Kamikihito for the treatment of anxiety and insomnia in castration resistant prostate cancer patients
KAMIKIHITO study for castration resistant prostate cancer patients
Safety and efficacy of Kamikihito for the treatment of anxiety and insomnia in castration resistant prostate cancer patients
KAMIKIHITO study for castration resistant prostate cancer patients
Japan |
Anxiety insomnia and fatigue induced by hormone therapy
Medicine in general | Urology |
Malignancy
NO
To evaluate cancer related fatigue objectively and efficacy of kamikihito for anxiety and insomnia and fatigue in cancer patients
Safety,Efficacy
Exploratory
Phase I,II
Effect of kamikihito on anxiety and insomnia at pre, 4 weeks, 8 weeks and 12 weeks by questionnaire.
Effect of kamikihito on fatugue at pre, 4 weeks, 8 weeks and 12 weeks by questionnaire and objective evaluation.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Medicine |
Administration of kamikihito
20 | years-old | <= |
Not applicable |
Male
Castration resistant prostate cancer patients under hormone therapy with anxiety and insomnia.
1)Heart disease
2)Severely lung disease
3)Cranial nerve disease with unconsciousness
4)Liver disease more than grade 2
5) Severely drug hypersensitivity
6)Kampo administration within 2 weeks
7) Not appropriate for the study at the physician's assessment
30
1st name | Satoshi |
Middle name | |
Last name | Tamada |
Osaka City University
Urology
5458585
1-4-3, Asahimachi, Abeno-ku, Osaka City
06-6645-3857
s-tamada@med.osaka-cu.ac.jp
1st name | Satoshi |
Middle name | |
Last name | Tamada |
Osaka City University
Urology
5458585
1-4-3, Asahimachi, Abeno-ku, Osaka City
06-6645-3857
s-tamada@med.osaka-cu.ac.jp
Osaka City University
TSUMURA & CO.
Profit organization
TSUMURA Research Laboratories
Ethical Committee of Osaka City University Graduate School of Medicine
1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan
06-6645-3456
ethics@med.osaka-cu.ac.jp
NO
2016 | Year | 06 | Month | 02 | Day |
https://onlinelibrary.wiley.com/doi/10.1002/tkm2.1298
Published
https://onlinelibrary.wiley.com/doi/10.1002/tkm2.1298
11
Kamikihito improved CFS and CES-D scores, thus improving fatigue and depression in enzalutamide-treated patients; however, it did not improve oxidative stress levels. Further, actigraphy showed prolongation of sleeping time, while the levels of various cytokines showed no change. Metabolomics analysis confirmed decrease in lipids and increase in amino acids that correlated with improvement in fatigue.
2021 | Year | 12 | Month | 06 | Day |
All participants provided written informed consent as a condition of enrollment in the trial.
Eleven patients undergoing treatment with enzalutamide for CRPC were included.
These patients were administered kamikihito, and evaluated for fatigue, depression, and insomnia, as described below.
Somnolence (one patient)
fatigue, depression, oxidative stress, various cytokines, insomnia (actigraphy), metabolites
Completed
2016 | Year | 01 | Month | 25 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 06 | Month | 02 | Day |
2017 | Year | 08 | Month | 04 | Day |
2016 | Year | 05 | Month | 31 | Day |
2021 | Year | 12 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025988
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |